{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:54:12Z","timestamp":1743267252538,"version":"3.37.3"},"reference-count":23,"publisher":"American Society of Hematology","issue":"17","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,10]]},"DOI":"10.1182\/bloodadvances.2024013434","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T19:08:27Z","timestamp":1721329707000},"page":"4559-4562","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Transformation of marginal zone lymphoma to Hodgkin lymphoma"],"prefix":"10.1182","volume":"8","author":[{"given":"Kamilia N.","family":"Moalem","sequence":"first","affiliation":[{"name":"1Department of Medicine, University of Miami and Jackson Memorial Hospital, Miami, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2690-3377","authenticated-orcid":false,"given":"Juan Pablo","family":"Alderuccio","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Department of Medicine, University of Miami and Sylvester Comprehensive Cancer Center, Miami, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00f4me","family":"Bommier","sequence":"additional","affiliation":[{"name":"3Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Habermann","sequence":"additional","affiliation":[{"name":"3Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5084-0698","authenticated-orcid":false,"given":"Brian K.","family":"Link","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine, University of Iowa, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-178X","authenticated-orcid":false,"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[{"name":"5Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Florindez","sequence":"additional","affiliation":[{"name":"6Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9346-9013","authenticated-orcid":false,"given":"Izidore S.","family":"Lossos","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Department of Medicine, University of Miami and Sylvester Comprehensive Cancer Center, Miami, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"issue":"1","key":"2024091012503419600_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol"},{"key":"2024091012503419600_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/aol-20-28","article-title":"Epidemiology of marginal zone lymphoma","volume":"5","author":"Cerhan","year":"2021","journal-title":"Ann Lymphoma"},{"issue":"21","key":"2024091012503419600_bib3","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1002\/cncr.33117","article-title":"Splenic marginal zone lymphoma: a US population-based survival analysis (1999-2016)","volume":"126","author":"Florindez","year":"2020","journal-title":"Cancer"},{"issue":"17","key":"2024091012503419600_bib4","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1182\/blood-2015-11-624312","article-title":"Splenic marginal zone lymphoma: from genetics to management","volume":"127","author":"Arcaini","year":"2016","journal-title":"Blood"},{"issue":"1-2","key":"2024091012503419600_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.beha.2016.12.001","article-title":"Marginal zone lymphomas: reconsidering similarities and differences while moving towards personalized treatment","volume":"30","author":"Zucca","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1","key":"2024091012503419600_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/annonc\/mdt507","article-title":"Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma","volume":"25","author":"Meyer","year":"2014","journal-title":"Ann Oncol"},{"issue":"16","key":"2024091012503419600_bib7","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1200\/JCO.2006.05.6150","article-title":"Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma","volume":"24","author":"Sagaert","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2024091012503419600_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41408-023-00903-w","article-title":"A\u00a0population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics","volume":"13","author":"Bult","year":"2023","journal-title":"Blood Cancer J"},{"issue":"10","key":"2024091012503419600_bib9","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/ajh.27058","article-title":"Marginal zone lymphoma: 2023 update on diagnosis and management","volume":"98","author":"Cheah","year":"2023","journal-title":"Am J Hematol"},{"issue":"34","key":"2024091012503419600_bib10","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1200\/JCO.18.00138","article-title":"Risk factors for transformation to higher-grade lymphoma and its impact on survival in a large cohort of patients with marginal zone lymphoma from a single institution","volume":"36","author":"Alderuccio","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"2024091012503419600_bib11","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/annonc\/mdv368","article-title":"Histologic transformation in marginal zone lymphomas\u2020","volume":"26","author":"Conconi","year":"2015","journal-title":"Ann Oncol"},{"issue":"7","key":"2024091012503419600_bib12","first-page":"e26738","article-title":"Splenic marginal zone lymphoma with histological transformation to Hodgkin's lymphoma","volume":"14","author":"Veeraballi","year":"2022","journal-title":"Cureus"},{"issue":"5","key":"2024091012503419600_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jclinpath-2018-205678","article-title":"Transformation of a splenic marginal zone lymphoma into classic Hodgkin lymphoma","volume":"72","author":"Menter","year":"2019","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"2024091012503419600_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/bjh.17815","article-title":"Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation","volume":"196","author":"Bastidas-Mora","year":"2022","journal-title":"Br J Haematol"},{"issue":"1","key":"2024091012503419600_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/adpa.2002.30611","article-title":"Hodgkin-like transformation of a marginal zone B-cell lymphoma of the larynx","volume":"6","author":"Fung","year":"2002","journal-title":"Ann Diagn Pathol"},{"issue":"6","key":"2024091012503419600_bib16","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/ije\/dyx119","article-title":"Cohort profile: the Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) cohort study","volume":"46","author":"Cerhan","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"6","key":"2024091012503419600_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/ijc.34773","article-title":"Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: a population-based study","volume":"154","author":"Du","year":"2024","journal-title":"Int J Cancer"},{"issue":"1","key":"2024091012503419600_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41408-023-00831-9","article-title":"Transformation and survival in marginal zone lymphoma: a Finnish nationwide population-based study","volume":"13","author":"Kalashnikov","year":"2023","journal-title":"Blood Cancer J"},{"issue":"11","key":"2024091012503419600_bib19","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1016\/j.clml.2021.06.013","article-title":"Clinical characteristics, treatment and evolution of splenic and nodal marginal zone lymphomas-retrospective and multicentric analysis of Portuguese centers","volume":"21","author":"Rodrigues","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"11","key":"2024091012503419600_bib20","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.3324\/haematol.2020.256388","article-title":"Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration","volume":"106","author":"Stephens","year":"2021","journal-title":"Haematologica"},{"issue":"2","key":"2024091012503419600_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2559.2005.02046.x","article-title":"Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases","volume":"46","author":"Zettl","year":"2005","journal-title":"Histopathology"},{"key":"2024091012503419600_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2016.04.019","article-title":"Hodgkin lymphoma variant of Richter transformation: morphology, Epstein Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion","volume":"55","author":"Xiao","year":"2016","journal-title":"Hum Pathol"},{"issue":"1","key":"2024091012503419600_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1182\/blood.V83.1.223.223","article-title":"The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma","volume":"83","author":"LeBrun","year":"1994","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/17\/4559\/2241152\/blooda_adv-2024-013434-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/17\/4559\/2241152\/blooda_adv-2024-013434-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T12:51:09Z","timestamp":1725972669000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/17\/4559\/517070\/Transformation-of-marginal-zone-lymphoma-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":23,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024013434","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"type":"print","value":"2473-9529"},{"type":"electronic","value":"2473-9537"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}